Correlation Between Abcellera Biologics and Canon
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Canon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Canon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and Canon Inc ADR, you can compare the effects of market volatilities on Abcellera Biologics and Canon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Canon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Canon.
Diversification Opportunities for Abcellera Biologics and Canon
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Abcellera and Canon is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Canon Inc ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canon Inc ADR and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Canon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canon Inc ADR has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Canon go up and down completely randomly.
Pair Corralation between Abcellera Biologics and Canon
If you would invest 300.00 in Abcellera Biologics on October 7, 2024 and sell it today you would earn a total of 13.00 from holding Abcellera Biologics or generate 4.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 5.0% |
| Values | Daily Returns |
Abcellera Biologics vs. Canon Inc ADR
Performance |
| Timeline |
| Abcellera Biologics |
| Canon Inc ADR |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Abcellera Biologics and Canon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abcellera Biologics and Canon
The main advantage of trading using opposite Abcellera Biologics and Canon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Canon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canon will offset losses from the drop in Canon's long position.| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |